Leqvio is a prescription injectable used to lower LDL cholesterol in adults with atherosclerotic cardiovascular disease or familial hypercholesterolemia. It contains inclisiran, a small interfering RNA that reduces PCSK9 production, enhancing LDL receptor activity. Administered by a healthcare professional, it offers a convenient dosing schedule: initial dose, then at 3 months, and every 6 months thereafter.. Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
